In a transgenic mouse model of inflammation-driven cancer, we have previously shown that macrophage S1PR1 signaling is crucial for lymphangiogenesis by activating the NLRP3 inflammasome and subsequent activation of IL-1β release. Here, NLRP3 is linked to cancer.